|
1
|
Maes OC, Chertkow HM, Wang E and Schipper
HM: MicroRNA: Implications for Alzheimer disease and other human
CNS disorders. Curr Genomics. 10:154–168. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xu J, Li Y, Wang F, et al: Suppressed
miR-424 expression via upregulation of target gene Chk1 contributes
to the progression of cervical cancer. Oncogene. 32:976–987. 2013.
View Article : Google Scholar
|
|
3
|
Farazi TA, Hoell JI, Morozov P and Tuschl
T: MicroRNAs in human cancer. Adv Exp Med Biol. 774:1–20. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Singaravelu R, Chen R, Lyn RK, et al:
Hepatitis C virus induced up-regulation of microRNA-27: A novel
mechanism for hepatic steatosis. Hepatology. 59:98–108. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huang J, Wang F, Argyris E, et al:
Cellular microRNAs contribute to HIV-1 latency in resting primary
CD4+ T lymphocytes. Nat Med. 13:1241–1247. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang S, Qiu L, Yan X, et al: Loss of
microRNA 122 expression in patients with hepatitis B enhances
hepatitis B virus replication through cyclin G(1)-modulated P53
activity. Hepatology. 55:730–741. 2012. View Article : Google Scholar
|
|
7
|
Lajer CB, Garnaes E, Friis-Hansen L, et
al: The role of miRNAs in human papilloma virus (HPV)-associated
cancers: bridging between HPV-related head and neck cancer and
cervical cancer. Br J Cancer. 106:1526–1534. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lagos-Quintana M, Rauhut R, Yalcin A,
Meyer J, Lendeckel W and Tuschl T: Identification of
tissue-specific microRNAs from mouse. Curr Biol. 12:735–739. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chang J, Provost P and Taylor JM:
Resistance of human hepatitis delta virus RNAs to dicer activity. J
Virol. 77:11910–11917. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jopling CL, Schütz S and Sarnow P:
Position-dependent function for a tandem microRNA miR-122-binding
site located in the hepatitis C virus RNA genome. Cell Host
Microbe. 4:77–85. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Coulouarn C, Factor VM, Andersen JB,
Durkin ME and Thorgeirsson SS: Loss of miR-122 expression in liver
cancer correlates with suppression of the hepatic phenotype and
gain of metastatic properties. Oncogene. 28:3526–3536. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Castoldi M, Vujic Spasic M, Altamura S, et
al: The liver-specific microRNA miR-122 controls systemic iron
homeostasis in mice. J Clin Invest. 121:1386–1396. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Esau C, Davis S, Murray SF, et al: miR-122
regulation of lipid metabolism revealed by in vivo antisense
targeting. Cell Metab. 3:87–98. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Burns DM, D’Ambrogio A, Nottrott S and
Richter JD: CPEB and two poly(A) polymerases control miR-122
stability and p53 mRNA translation. Nature. 473:105–108. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wen J and Friedman JR: miR-122 regulates
hepatic lipid metabolism and tumor suppression. J Clin Invest.
122:2773–2776. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shan Y, Zheng J, Lambrecht RW and
Bonkovsky HL: Reciprocal effects of micro-RNA-122 on expression of
heme oxygenase-1 and hepatitis C virus genes in human hepatocytes.
Gastroenterology. 133:1166–1174. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jopling CL, Yi M, Lancaster AM, Lemon SM
and Sarnow P: Modulation of hepatitis C virus RNA abundance by a
liver-specific MicroRNA. Science. 309:1577–1581. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Krutzfeldt J, Rajewsky N, Braich R, et al:
Silencing of microRNAs in vivo with ‘antagomirs’. Nature.
438:685–689. 2005. View Article : Google Scholar
|
|
19
|
Trebicka J, Anadol E, Elfimova N, et al:
Hepatic and serum levels of miR-122 after chronic HCV-induced
fibrosis. J Hepatol. 58:234–239. 2013. View Article : Google Scholar
|
|
20
|
Choi Y, Dienes HP and Krawczynski K:
Kinetics of miR-122 expression in the liver during acute HCV
infection. PloS One. 8:e765012013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ebert MS, Neilson JR and Sharp PA:
MicroRNA sponges: competitive inhibitors of small RNAs in mammalian
cells. Nat Methods. 4:721–726. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ho HH and Ivashkiv LB: Role of STAT3 in
type I interferon responses. Negative regulation of STAT1-dependent
inflammatory gene activation. J Biol Chem. 281:14111–14118. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ge D, Fellay J, Thompson AJ, et al:
Genetic variation in IL28B predicts hepatitis C treatment-induced
viral clearance. Nat. 461:399–401. 2009. View Article : Google Scholar
|
|
24
|
Ohata K, Hamasaki K, Toriyama K, et al:
Hepatic steatosis is a risk factor for hepatocellular carcinoma in
patients with chronic hepatitis C virus infection. Cancer.
97:3036–3043. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Minegishi Y, Saito M, Tsuchiya S, et al:
Dominant-negative mutations in the DNA-binding domain of STAT3
cause hyper-IgE syndrome. Nature. 448:1058–1062. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang WB, Levy DE and Lee CK: STAT3
negatively regulates type I IFN-mediated antiviral response. J
Immunol. 187:2578–2585. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Qiu L, Fan H, Jin W, et al:
miR-122-induced down-regulation of HO-1 negatively affects
miR-122-mediated suppression of HBV. Biochem Bioph Res Co.
398:771–777. 2010. View Article : Google Scholar
|
|
28
|
Jopling CL: Regulation of hepatitis C
virus by microRNA-122. Biochem Soc Trans. 36(Pt 6): 1220–1223.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mortimer SA and Doudna JA: Unconventional
miR-122 binding stabilizes the HCV genome by forming a trimolecular
RNA structure. Nucleic Acids Res. 41:4230–4240. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kambara H, Fukuhara T, Shiokawa M, et al:
Establishment of a novel permissive cell line for the propagation
of hepatitis C virus by expression of microRNA miR122. J Virol.
86:1382–1393. 2012. View Article : Google Scholar :
|
